The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatments (tx) after progression to first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts): A pooled analysis of TRIBE and MOMA studies by GONO group.
 
Daniele Rossini
No Relationships to Disclose
 
Roberto Moretto
No Relationships to Disclose
 
Chiara Cremolini
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck; Roche
 
Vittorina Zagonel
Travel, Accommodations, Expenses - Roche
 
Giuseppe Tonini
Consulting or Advisory Role - Molteni Farmaceutici; Novartis; Pierre Fabre; Roche
 
Vincenzo Ricci
Honoraria - Celgene; Merck Serono; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche
 
Giuseppe Aprile
No Relationships to Disclose
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Bayer
Speakers' Bureau - Lilly; Roche
Research Funding - Sanofi
 
Gianluca Tomasello
No Relationships to Disclose
 
Emanuela Dell'Aquila
No Relationships to Disclose
 
Giacomo Allegrini
No Relationships to Disclose
 
Francesca Bergamo
No Relationships to Disclose
 
Marialaura Mancini
No Relationships to Disclose
 
Carlotta Antoniotti
No Relationships to Disclose
 
Monica Ronzoni
No Relationships to Disclose
 
Alberto Zaniboni
No Relationships to Disclose
 
Federica Marmorino
No Relationships to Disclose
 
Sara Bustreo
No Relationships to Disclose
 
Elena Mori
No Relationships to Disclose
 
Alfredo Falcone
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck; Roche; SERVIER
Research Funding - Amgen; Bayer; Lilly; Merck; Roche; SERVIER